Annual EBITDA:
-$109.58M+$67.87M(+38.25%)Summary
- As of today, NVCR annual EBITDA is -$109.58 million, with the most recent change of +$67.87 million (+38.25%) on December 31, 2024.
- During the last 3 years, NVCR annual EBITDA has fallen by -$71.20 million (-185.49%).
- NVCR annual EBITDA is now -344.42% below its all-time high of $44.83 million, reached on December 31, 2020.
Performance
NVCR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$32.36M+$3.72M(+10.31%)Summary
- As of today, NVCR quarterly EBITDA is -$32.36 million, with the most recent change of +$3.72 million (+10.31%) on September 30, 2025.
- Over the past year, NVCR quarterly EBITDA has dropped by -$2.72 million (-9.19%).
- NVCR quarterly EBITDA is now -288.02% below its all-time high of $17.21 million, reached on September 30, 2020.
Performance
NVCR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$162.22M-$2.72M(-1.71%)Summary
- As of today, NVCR TTM EBITDA is -$162.22 million, with the most recent change of -$2.72 million (-1.71%) on September 30, 2025.
- Over the past year, NVCR TTM EBITDA has dropped by -$22.89 million (-16.42%).
- NVCR TTM EBITDA is now -474.42% below its all-time high of $43.33 million, reached on March 31, 2021.
Performance
NVCR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NVCR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +38.3% | -9.2% | -16.4% |
| 3Y3 Years | -185.5% | -47.4% | -173.3% |
| 5Y5 Years | -911.1% | -288.0% | -687.6% |
NVCR EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -185.5% | +38.3% | -47.4% | +46.0% | -173.3% | +24.6% |
| 5Y | 5-Year | -344.4% | +38.3% | -288.0% | +46.0% | -474.4% | +24.6% |
| All-Time | All-Time | -344.4% | +38.3% | -288.0% | +46.0% | -474.4% | +24.6% |
NVCR EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$32.36M(+10.3%) | -$162.22M(-1.7%) |
| Jun 2025 | - | -$36.08M(-4.4%) | -$159.50M(-3.5%) |
| Mar 2025 | - | -$34.54M(+41.7%) | -$154.17M(+1.4%) |
| Dec 2024 | -$109.58M(+38.2%) | -$59.25M(-99.9%) | -$156.30M(-12.2%) |
| Sep 2024 | - | -$29.63M(+3.6%) | -$139.34M(+15.6%) |
| Jun 2024 | - | -$30.75M(+16.2%) | -$165.14M(+15.0%) |
| Mar 2024 | - | -$36.67M(+13.3%) | -$194.33M(+9.7%) |
| Dec 2023 | -$177.45M(-161.4%) | -$42.28M(+23.7%) | -$215.19M(-0.9%) |
| Sep 2023 | - | -$55.44M(+7.5%) | -$213.19M(-18.6%) |
| Jun 2023 | - | -$59.94M(-4.2%) | -$179.70M(-30.0%) |
| Mar 2023 | - | -$57.53M(-42.8%) | -$138.23M(-75.2%) |
| Dec 2022 | -$67.89M(-76.9%) | -$40.28M(-83.5%) | -$78.90M(-32.9%) |
| Sep 2022 | - | -$21.95M(-18.8%) | -$59.35M(-37.3%) |
| Jun 2022 | - | -$18.47M(-1124.1%) | -$43.22M(-25.1%) |
| Mar 2022 | - | $1.80M(+108.7%) | -$34.56M(-1.4%) |
| Dec 2021 | -$38.38M(-185.6%) | -$20.73M(-256.3%) | -$34.08M(-2907.4%) |
| Sep 2021 | - | -$5.82M(+40.7%) | $1.21M(-95.0%) |
| Jun 2021 | - | -$9.81M(-530.1%) | $24.24M(-44.0%) |
| Mar 2021 | - | $2.28M(-84.3%) | $43.33M(+9.5%) |
| Dec 2020 | $44.83M(+231.9%) | $14.56M(-15.4%) | $39.55M(+43.3%) |
| Sep 2020 | - | $17.21M(+85.7%) | $27.61M(+70.6%) |
| Jun 2020 | - | $9.27M(+720.8%) | $16.18M(+58.0%) |
| Mar 2020 | - | -$1.49M(-157.0%) | $10.24M(+35.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $13.51M(+165.4%) | $2.62M(-54.7%) | $7.54M(+592.2%) |
| Sep 2019 | - | $5.79M(+73.9%) | -$1.53M(+85.1%) |
| Jun 2019 | - | $3.33M(+179.4%) | -$10.26M(+44.2%) |
| Mar 2019 | - | -$4.19M(+35.1%) | -$18.38M(+25.5%) |
| Dec 2018 | -$20.67M(+32.4%) | -$6.46M(-120.1%) | -$24.67M(-20.0%) |
| Sep 2018 | - | -$2.94M(+38.8%) | -$20.56M(+4.3%) |
| Jun 2018 | - | -$4.80M(+54.2%) | -$21.49M(+29.3%) |
| Mar 2018 | - | -$10.47M(-345.1%) | -$30.41M(+3.9%) |
| Dec 2017 | -$30.56M(+72.2%) | -$2.35M(+39.1%) | -$31.65M(+30.6%) |
| Sep 2017 | - | -$3.87M(+71.8%) | -$45.59M(+33.4%) |
| Jun 2017 | - | -$13.72M(-17.1%) | -$68.43M(+18.7%) |
| Mar 2017 | - | -$11.71M(+28.1%) | -$84.13M(+18.5%) |
| Dec 2016 | -$109.88M(-8.1%) | -$16.29M(+39.0%) | -$103.25M(+11.3%) |
| Sep 2016 | - | -$26.71M(+9.2%) | -$116.42M(-3.0%) |
| Jun 2016 | - | -$29.42M(+4.6%) | -$113.05M(-2.5%) |
| Mar 2016 | - | -$30.84M(-4.7%) | -$110.25M(-9.4%) |
| Dec 2015 | -$101.62M(-29.8%) | -$29.45M(-26.2%) | -$100.81M(-41.3%) |
| Sep 2015 | - | -$23.34M(+12.3%) | -$71.35M(-48.6%) |
| Jun 2015 | - | -$26.62M(-24.4%) | -$48.01M(-13.9%) |
| Mar 2015 | - | -$21.39M(-3.1%) | -$42.14M(-10.1%) |
| Dec 2014 | -$78.30M(-14.1%) | - | - |
| Jun 2014 | - | -$20.75M(-18.3%) | -$38.29M(-118.3%) |
| Mar 2014 | - | -$17.54M | -$17.54M |
| Dec 2013 | -$68.64M | - | - |
FAQ
- What is NovoCure Limited annual EBITDA?
- What is the all-time high annual EBITDA for NovoCure Limited?
- What is NovoCure Limited annual EBITDA year-on-year change?
- What is NovoCure Limited quarterly EBITDA?
- What is the all-time high quarterly EBITDA for NovoCure Limited?
- What is NovoCure Limited quarterly EBITDA year-on-year change?
- What is NovoCure Limited TTM EBITDA?
- What is the all-time high TTM EBITDA for NovoCure Limited?
- What is NovoCure Limited TTM EBITDA year-on-year change?
What is NovoCure Limited annual EBITDA?
The current annual EBITDA of NVCR is -$109.58M
What is the all-time high annual EBITDA for NovoCure Limited?
NovoCure Limited all-time high annual EBITDA is $44.83M
What is NovoCure Limited annual EBITDA year-on-year change?
Over the past year, NVCR annual EBITDA has changed by +$67.87M (+38.25%)
What is NovoCure Limited quarterly EBITDA?
The current quarterly EBITDA of NVCR is -$32.36M
What is the all-time high quarterly EBITDA for NovoCure Limited?
NovoCure Limited all-time high quarterly EBITDA is $17.21M
What is NovoCure Limited quarterly EBITDA year-on-year change?
Over the past year, NVCR quarterly EBITDA has changed by -$2.72M (-9.19%)
What is NovoCure Limited TTM EBITDA?
The current TTM EBITDA of NVCR is -$162.22M
What is the all-time high TTM EBITDA for NovoCure Limited?
NovoCure Limited all-time high TTM EBITDA is $43.33M
What is NovoCure Limited TTM EBITDA year-on-year change?
Over the past year, NVCR TTM EBITDA has changed by -$22.89M (-16.42%)